Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? - Wikidata - awgldk - TriplyDB

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

http://www.wikidata.org/entity/Q40281693

about

Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol Caspase 2 activation and ER stress drive rapid Jurkat cell apoptosis by clofibrate NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolism Cancer stem cells: the development of new cancer therapeutics.Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells.PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.Dysbiosis of gut microbiota in promoting the development of colorectal cancer.Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.

P2860

Q33883373-C9FC98A9-9C2E-41A1-8E98-8AE6A43B870F Q34134358-894E2117-D097-431E-9159-22F49068A09B Q34149341-871FEA37-91A7-4F35-9D47-172B44849EE7 Q34428761-F48DC491-2BD6-451D-AFD6-5D63FDEB1DF1 Q36413381-77D7072A-E349-4D0E-B4D2-F9880518E2D3 Q36781253-64C5E699-7AD2-4330-94D3-6CE5866BCA39 Q37861207-C915AA54-D9C7-493B-98A8-000537DDD93A Q38941022-F5CA083B-FEBB-4D10-BF30-731E66049517 Q39609137-507521F5-1830-4909-ABB5-C8C538C81CAC Q39689666-F11D0C25-911F-49D9-88BB-9A004163619B Q42250957-851B201D-75C4-442D-AA95-D646BFED88A9 Q50233365-95B37D23-E92D-4993-BFE4-6CB2A5EA9012 Q55279633-BBB8C20D-5202-481C-91DE-5B65553F1359

P2860

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

http://www.wikidata.org/entity/Q40281693

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

@en

type

label

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

@en

prefLabel

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

@en

P1433

Q40281693-8DE7F45A-D8D8-4ECC-852B-EA0A779C6C3C

P1476

Q40281693-FD131890-AF61-4A4A-A79E-91FA0038F15E

P2093

Q40281693-48D0E4A4-4C76-460A-9681-E717CD5539D7

Q40281693-D4D465A1-5003-4BB2-8C52-7091A52CDCC5

P2860

Q40281693-0554B825-FA4C-487B-ADA4-0CA825AC229E

Q40281693-05A48B4D-8EC2-4B32-93C2-EE8BA66032E2

Q40281693-0800DB6E-410B-45D3-9B6B-74B9424A80D6

Q40281693-0919D892-D2D6-46E9-A7DB-C602E7E7B0FE

Q40281693-0A227935-C80A-4F22-B089-DFA610E51DAE

Q40281693-0BB0B9F1-90B5-4FA9-9FF9-F416B7550CA2

Q40281693-0C6BA235-C0D3-4B55-BBB4-F39306D194D4

Q40281693-0DBD1CCA-3286-415F-8E58-8DC6560351B4

Q40281693-25CDA59B-3677-401A-908A-3B6B95D7CDAD

Q40281693-272682AE-F3FB-470D-B6CF-6F56ADC8A634

P304

Q40281693-402CFF86-D16B-4AAA-8395-3E4FA795BB4D

P31

Q40281693-50C5160B-8520-4EBB-B3F6-D568A4ED74F6

P356

Q40281693-AE60ED4C-EE7A-4266-A6EA-83D6C8288731

P478

Q40281693-82A366BF-9B93-4602-84B6-FA2F976ABE81

P50

Q40281693-E8325E31-E557-4FA5-9C55-6283A255B312

P577

Q40281693-D8CA8703-9671-4555-9960-A5C4BA3DCEE8

P5875

Q40281693-040F258D-E0F2-4313-AEBB-DD6064506193

P698

Q40281693-FEFBBD51-AB43-455D-A81F-F07D657F417A

P932

Q40281693-DC86BED5-5DC1-4FFE-818B-684568CD754B

P356

P1433

P1476

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

@en

P2093

Bruno Giardina

http://www.w3.org/2001/XMLSchema#string

Roberto Scatena

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors

Energy metabolism in tumor cells

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

Peroxisome proliferator-activated receptors: nuclear control of metabolism

P304

256251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2008/256251

http://www.w3.org/2001/XMLSchema#string

P478

2008

http://www.w3.org/2001/XMLSchema#string

P50

Patrizia Bottoni

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51419496

http://www.w3.org/2001/XMLSchema#string

P698

18645611

http://www.w3.org/2001/XMLSchema#string

P932

2464819

http://www.w3.org/2001/XMLSchema#string